Marie‐Eve Lalonde - Concepedia

Author

Marie‐Eve Lalonde

Université de Montréal

Also Known As

Lalonde, Marie-Eve, M-E. Lalonde, M.-E. Lalonde, Marie-Eve Lalonde, Marie‐Eve Lalonde, Yang, Xiang-Jiao

Publications

Citations

H-Index

Concepts

All Affiliations

Université de Montréal Université Laval Centre Hospitalier Universitaire Sainte-Justine Hôtel-Dieu de Québec University of Toronto

About

Marie‐Eve Lalonde is an author at Université de Montréal specializing in natural sciences, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	186
2	Natural Sciences	4	4	363
3	Cell Biology	4	4	186
4	Biochemistry	2	2	200
5	Cellular Physiology	1	1	13

Marie‐Eve Lalonde

Publications

773

Citations

H-Index

Page 1

	Year	Citations
Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1 Catherine A. Musselman, Nikita Avvakumov, Reiko Watanabe, Nature Structural & Molecular Biology Molecular CharacterizationBiochemistryStructural BioinformaticsNatural SciencesMolecular Biology	2012	187
Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity Marie‐Eve Lalonde, Nikita Avvakumov, Karen C. Glass, Genes & Development	2013	182
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway Mélissa Carbonneau, Laurence M. Gagné, Marie‐Eve Lalonde, Nature Communications	2016	176
<scp>BRPF</scp> 3‐ <scp>HBO</scp> 1 regulates replication origin activation and histone H3K14 acetylation Yunpeng Feng, Arsenios Vlassis, Céline Lopez‐Roques, The EMBO Journal Molecular RegulationMolecular BiologyEpigeneticsHistone H3k14 AcetylationTranscriptional Regulation	2015	142
Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci Deepthi Sudarshan, Nikita Avvakumov, Marie‐Eve Lalonde, Genes & Development	2022	23
Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia Marie‐Eve Lalonde, Marc Sasseville, Anne-Marie Gélinas, Haematologica Novel Therapeutic VulnerabilityMixed-phenotype Acute LeukemiaMolecular BiologyRefractory AllGenome Engineering	2022	21
Identification of functional DNA variants in the constitutive promoter region of MDM2 Marie‐Eve Lalonde, Manon Ouimet, Mathieu Larivière, Human Genomics	2012	19
Production of α2,6-sialylated and non-fucosylated recombinant alpha-1-antitrypsin in CHO cells Marie‐Eve Lalonde, Izel Koyuturk, Denis Brochu, Journal of Biotechnology BiochemistryNatural SciencesImmunologyCho CellsCellular Biochemistry	2019	13
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia Rocío Sánchez, Jérôme St‐Cyr, Marie‐Eve Lalonde, Haematologica Mixed-phenotype Acute LeukemiaGeneticsApoptosisImmunologyCell Death	2013	10

Page 1